Citations

Showing 10 of 108104 citations.

Significant up-regulation of vasodilator-stimulated phosphoprotein in human pancreatic duct adenocarcinoma.
Tu, Yifan , Kang, Ningling , Poddar, Nishant , Lai, Jinping , Muthusamy, Selvaraj

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15674-e15674

10.1200/jco.2016.34.15_suppl.e15674 Get It

Safety and efficacy of durvalumab (MEDI4736), a PD-L1 antibody, in urothelial bladder cancer.
Massard, Christophe, Sharma, Sunil, Rafii, Saeed , Colón‐Otero, Gerardo , Hamid, Omid , O’Donnell, Peter H. , Drakaki, Alexandra , Kurland, John F. , Rebelatto, Marlon C., Jin, Xiaoping , Blake-Haskins, John A., Gupta, Ashok , Rafii, Saeed , Gordon, Michael S. , Wainberg, Zev A. , Luke, Jason J. , Curiel, Tyler Jay , Sanborn, Rachel E , Drakaki, Alexandra , Segal, Neil Howard

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4502-4502

10.1200/jco.2016.34.15_suppl.4502 Get It

Deletions in HSP110 T17 and patient prognosis in stage III microsatellite instable (MSI) colon cancers: Findings from CALGB 89803 and NCCTG N0147.
Tomšič, Jerneja , Meyers, Jeffrey P., Timmers, Cynthia , Niedzwiecki, Donna , Chapelle, Albert de la , Goldberg, Richard M. , Niedzwiecki, Donna , Wu, Christina , Shi, Qian , Frankel, Wendy L. , Saltz, Leonard B. , Alberts, Steven R. , Sargent, Daniel J. , Hampel, Heather

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15148-e15148

10.1200/jco.2016.34.15_suppl.e15148 Get It

Association of chemotherapy induced neutropenia at 1-month mark (CIN-1-month) and overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: A Cohort study.
Shitara, Kohei , Ohtsu, Atsushi , Ramanathan, Ramesh K., Höchster, Howard S. , Kasi, Pashtoon Murtaza , Kotani, Daisuke , Cecchini, Michael , Grothey, Axel , Yoshino, Takayuki

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e15124-e15124

10.1200/jco.2016.34.15_suppl.e15124 Get It

Evofosfamide combined with gemcitabine/nab-paclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial.
Kwak, Eunice L., Ibrahim, Ayman, Borad, Mitesh J. , Wang‐Gillam, Andrea , Aldridge, Julie , Olszanski, Anthony J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4114-4114

10.1200/jco.2016.34.15_suppl.4114 Get It

Randomized phase 2 study of paclitaxel (PTX), trastuzumab (T) with or without MM-111 in HER2 expressing gastroesophageal cancers (GEC).
Denlinger, Crystal S. , Sym, Sun Jin , Bendell, Johanna C. , Kudla, Art, McDonagh, Charlotte F., Czibere, Akos, Chibaudel, Benoist , Yoon, Harry H. , Hecht, J. Randolph, Bang, Yung‐Jue, Maqueda, María , Watkins, David J. , Park, Se Hoon , Arkenau, Hendrik‐Tobias , Bekaii‐Saab, Tanios , Press, Michael F. , Cunningham, David , Bang, Yung‐Jue , Chibaudel, Benoist

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4043-4043

10.1200/jco.2016.34.15_suppl.4043 Get It

NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE.
Wolin, Edward M. , Chasen, Beth, Kulke, Matthew H. , Caplin, Martyn , Baum, Richard P. , Hobday, Timothy J. , Hendifar, Andrew , Öberg, Kjell E., Sierra, Maribel Lopera , Kwekkeboom, Dik J., Ruszniewski, Philippe, Krenning, Eric P. , Kunz, Pamela L. , Strosberg, Jonathan , Bushnell, David

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4005-4005

10.1200/jco.2016.34.15_suppl.4005 Get It

Regorafenib in previously treated metastatic colorectal cancer (mCRC): Analysis of age subgroups in the open-label phase IIIb CONSIGN trial.
Seitz, Jean François, Hofheinz, Ralf‐Dieter , Arriaga, Yull , Verma, Udit, Grothey, Axel, Miriyala, Ashok, Kalmus, J., Kappeler, Christian, Zaniboni, Alberto , Cutsem, Eric Van , Ciardiello, Fortunato , Ychou, Marc , García‐Carbonero, Rocio , Falcone, Alfredo

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3524-3524

10.1200/jco.2016.34.15_suppl.3524 Get It

Association of tumor infiltrating lymphocytes (TILs) with molecular subtype and prognosis in stage III colon cancers (CC) from a FOLFOX-based adjuvant chemotherapy trial.
Smyrk, Thomas C. , Foster, Nathan R. , Meyers, Jeffrey P., Thibodeau, Stephen N. , Goldberg, Richard M. , Sinicrope, Frank A. , Shi, Qian , Sargent, Daniel J. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3518-3518

10.1200/jco.2016.34.15_suppl.3518 Get It

Impact of primary (1º) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).
Niedzwiecki, Donna , Innocenti, Federico , Fruth, Briant, Greene, Claire, O’Neil, Bert H. , Atkins, James N., Horvath, Laura E., Polite, Blasé N. , Goldberg, Richard M. , Höchster, Howard S. , Blanke, Charles D. , Schilsky, Richard L. , Lenz, Heinz‐Josef , Niedzwiecki, Donna , Venook, Alan P. , Shaw, James Edward , Meyerhardt, Jeffrey A. , O’Reilly, Eileen M. , Mayer, Robert J. , Bertagnolli, Monica M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 3504-3504

10.1200/jco.2016.34.15_suppl.3504 Get It